Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dexcom (DXCM) Inventory Average (2016 - 2025)

Historic Inventory Average for Dexcom (DXCM) over the last 17 years, with Q4 2025 value amounting to $616.6 million.

  • Dexcom's Inventory Average rose 923.91% to $616.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $616.6 million, marking a year-over-year increase of 923.91%. This contributed to the annual value of $585.8 million for FY2025, which is 630.56% up from last year.
  • Per Dexcom's latest filing, its Inventory Average stood at $616.6 million for Q4 2025, which was up 923.91% from $587.4 million recorded in Q3 2025.
  • In the past 5 years, Dexcom's Inventory Average registered a high of $616.6 million during Q4 2025, and its lowest value of $262.2 million during Q1 2021.
  • Its 5-year average for Inventory Average is $444.8 million, with a median of $426.7 million in 2023.
  • Per our database at Business Quant, Dexcom's Inventory Average surged by 10038.21% in 2021 and then plummeted by 1282.81% in 2022.
  • Quarter analysis of 5 years shows Dexcom's Inventory Average stood at $354.3 million in 2021, then dropped by 12.83% to $308.8 million in 2022, then surged by 71.31% to $529.1 million in 2023, then increased by 6.68% to $564.4 million in 2024, then rose by 9.24% to $616.6 million in 2025.
  • Its last three reported values are $616.6 million in Q4 2025, $587.4 million for Q3 2025, and $554.4 million during Q2 2025.